Precipio, Inc. (PRPO): Submission of Matters to a Vote of Security Holders
Precipio, Inc. (PRPO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001043961 0001043961 2026-06-15 2026-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of repo
How this was made
The 30-second read
Why it matters
Approves the Class II director slate (Richard Sandberg, Christina Valauri, Jeffrey Cossman, M.D.) and ratifies CBIZ CPAs, P.C. as independent registered public accounting firm for the year ending Dec. 31, 2026.
Market read
Standard governance/audit ratification with no disclosed operational or financial changes.
What to watch
Traders may instead focus on any concurrent proxy items not included here; this 8-K only covers Item 5.07 voting results.
Background
The company filed an SEC Form 8-K for Item 5.07, summarizing matters voted on at its Annual Meeting of stockholders.
Ticker impact
Precipio’s 8-K reports stockholder votes approving the election of three Class II directors and ratifying CBIZ as auditor for 2026.
Likely minimal near-term impact; any effect would be indirect via perceived governance/audit stability.
The filing discloses voting outcomes (director election and auditor ratification) without changes to strategy, guidance, financing, or litigation.
Market effects
No sector-level read-across; governance/audit ratification is company-specific and standard.
None indicated.
None indicated.
Counterpoint
If the market had been pricing governance uncertainty, the approved director slate and auditor ratification could reduce overhang, but the filing provides no evidence of such uncertainty.
Key entities
- issuerPrecipio, Inc.
Company convened its Annual Meeting and reported voting results for director election and auditor ratification.
- auditorCBIZ CPAs, P.C.
Independent registered public accounting firm ratified for the year ending Dec. 31, 2026.
- directorRichard Sandberg
Elected as Class II director for a term expiring in 2029.
- directorChristina Valauri
Elected as Class II director for a term expiring in 2029.
- directorJeffrey Cossman, M.D.
Elected as Class II director for a term expiring in 2029.
